Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Walsh SM, Sheridan RM, Lucas ED, Doan TA, Ware BC, Schafer J, Fu R, Burchill MA, Hesselberth JR, Tamburini BAJ. Molecular tracking devices quantify antigen distribution and archiving in the murine lymph node. Elife. 2021 Apr 12;10. doi: 10.7554/eLife.62781. PubMed PMID: 33843587; PubMed Central PMCID: PMC8116055.
Knitz MW, Bickett TE, Darragh LB, Oweida AJ, Bhatia S, Van Court B, Bhuvane S, Piper M, Gadwa J, Mueller AC, Nguyen D, Nangia V, Osborne DG, Bai X, Ferrara SE, Boss MK, Goodspeed A, Burchill MA, Tamburini BAJ, Chan ED, Pickering CR, Clambey ET, Karam SD. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis. J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001955. PubMed PMID: 33883256; PubMed Central PMCID: PMC8061827.
Burchill MA, Finlon JM, Goldberg AR, Gillen AE, Dahms PA, McMahan RH, Tye A, Winter AB, Reisz JA, Bohrnsen E, Schafer JB, D'Alessandro A, Orlicky DJ, Kriss MS, Rosen HR, McCullough RL, Jirón Tamburini BA. Oxidized Low-Density Lipoprotein Drives Dysfunction of the Liver Lymphatic System. Cell Mol Gastroenterol Hepatol. 2021;11(2):573-595. doi: 10.1016/j.jcmgh.2020.09.007. Epub 2020 Sep 19. PubMed PMID: 32961356; PubMed Central PMCID: PMC7803659.
Tuttle KD, Waugh KA, Araya P, Minter R, Orlicky DJ, Ludwig M, Andrysik Z, Burchill MA, Tamburini BAJ, Sempeck C, Smith K, Granrath R, Tracy D, Baxter J, Espinosa JM, Sullivan KD. JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. Cell Rep. 2020 Nov 17;33(7):108407. doi: 10.1016/j.celrep.2020.108407. PubMed PMID: 33207208; PubMed Central PMCID: PMC7727402.
Lucas ED, Schafer JB, Matsuda J, Kraus M, Burchill MA, Tamburini BAJ. PD-L1 Reverse Signaling in Dermal Dendritic Cells Promotes Dendritic Cell Migration Required for Skin Immunity. Cell Rep. 2020 Oct 13;33(2):108258. doi: 10.1016/j.celrep.2020.108258. PubMed PMID: 33053342; PubMed Central PMCID: PMC7688291.
Burchill MA, Goldberg AR, Tamburini BAJ. Emerging Roles for Lymphatics in Chronic Liver Disease. Front Physiol. 2019;10:1579. doi: 10.3389/fphys.2019.01579. eCollection 2019. Review. PubMed PMID: 31992991; PubMed Central PMCID: PMC6971163.
McGettigan B, McMahan R, Orlicky D, Burchill M, Danhorn T, Francis P, Cheng LL, Golden-Mason L, Jakubzick CV, Rosen HR. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. Hepatology. 2019 Jul;70(1):67-83. doi: 10.1002/hep.30401. Epub 2019 Feb 27. PubMed PMID: 30516830; PubMed Central PMCID: PMC6923128.
Tamburini BAJ, Finlon JM, Gillen AE, Kriss MS, Riemondy KA, Fu R, Schuyler RP, Hesselberth JR, Rosen HR, Burchill MA. Chronic Liver Disease in Humans Causes Expansion and Differentiation of Liver Lymphatic Endothelial Cells. Front Immunol. 2019;10:1036. doi: 10.3389/fimmu.2019.01036. eCollection 2019. PubMed PMID: 31156626; PubMed Central PMCID: PMC6530422.
Finlon JM, Burchill MA, Tamburini BAJ. Digestion of the Murine Liver for a Flow Cytometric Analysis of Lymphatic Endothelial Cells. J Vis Exp. 2019 Jan 7;(143). doi: 10.3791/58621. PubMed PMID: 30663671; PubMed Central PMCID: PMC6350926.
Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ. Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response. J Immunol. 2018 Sep 15;201(6):1735-1747. doi: 10.4049/jimmunol.1800271. Epub 2018 Jul 25. PubMed PMID: 30045970; PubMed Central PMCID: PMC6125167.
Kriss M, Burchill M. HCV and nonhepatic malignancy: Is pre-emptive direct-acting antiviral therapy indicated prior to treatment?. Hepatology. 2018 Jan;67(1):4-6. doi: 10.1002/hep.29414. Epub 2017 Nov 24. PubMed PMID: 28768054.
Burchill MA, Roby JA, Crochet N, Wind-Rotolo M, Stone AE, Edwards MG, Dran RJ, Kriss MS, Gale M Jr, Rosen HR. Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy. PLoS One. 2017;12(10):e0186213. doi: 10.1371/journal.pone.0186213. eCollection 2017. PubMed PMID: 29040318; PubMed Central PMCID: PMC5645093.
White JT, Cross EW, Burchill MA, Danhorn T, McCarter MD, Rosen HR, O'Connor B, Kedl RM. Virtual memory T cells develop and mediate bystander protective immunity in an IL-15-dependent manner. Nat Commun. 2016 Apr 21;7:11291. doi: 10.1038/ncomms11291. PubMed PMID: 27097762; PubMed Central PMCID: PMC4844673.
Burchill MA, Golden-Mason L, Wind-Rotolo M, Rosen HR. Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals. J Viral Hepat. 2015 Dec;22(12):983-91. doi: 10.1111/jvh.12465. Epub 2015 Oct 7. PubMed PMID: 26482547; NIHMSID:NIHMS1002018.
Burchill MA, Tamburini BA, Kedl RM. T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs. Eur J Immunol. 2015 Nov;45(11):3140-9. doi: 10.1002/eji.201545749. Epub 2015 Aug 3. PubMed PMID: 26179759; PubMed Central PMCID: PMC4674305.
Tamburini BA, Burchill MA, Kedl RM. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat Commun. 2014 Jun 6;5:3989. doi: 10.1038/ncomms4989. PubMed PMID: 24905362; PubMed Central PMCID: PMC4073648.
McKee AS, Burchill MA, Munks MW, Jin L, Kappler JW, Friedman RS, Jacobelli J, Marrack P. Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):E1122-31. doi: 10.1073/pnas.1300392110. Epub 2013 Feb 27. PubMed PMID: 23447566; PubMed Central PMCID: PMC3607057.
Burchill MA, Tamburini BA, Pennock ND, White JT, Kurche JS, Kedl RM. T cell vaccinology: exploring the known unknowns. Vaccine. 2013 Jan 2;31(2):297-305. doi: 10.1016/j.vaccine.2012.10.096. Epub 2012 Nov 6. Review. PubMed PMID: 23137843; PubMed Central PMCID: PMC3529748.
Oh JZ, Kurche JS, Burchill MA, Kedl RM. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway. Blood. 2011 Sep 15;118(11):3028-38. doi: 10.1182/blood-2011-04-348839. Epub 2011 Aug 2. PubMed PMID: 21813451; PubMed Central PMCID: PMC3175780.
Kurche JS, Burchill MA, Sanchez PJ, Haluszczak C, Kedl RM. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses. J Immunol. 2010 Aug 15;185(4):2106-15. doi: 10.4049/jimmunol.1000172. Epub 2010 Jul 16. PubMed PMID: 20639485; PubMed Central PMCID: PMC3863553.
Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J Immunol. 2008 Sep 1;181(5):3285-90. doi: 10.4049/jimmunol.181.5.3285. PubMed PMID: 18714000; PubMed Central PMCID: PMC2810104.
Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio CW, Vegoe AL, Hsieh CS, Jenkins MK, Farrar MA. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity. 2008 Jan;28(1):112-21. doi: 10.1016/j.immuni.2007.11.022. PubMed PMID: 18199418; PubMed Central PMCID: PMC2430111.
Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett. 2007 Nov 30;114(1):1-8. doi: 10.1016/j.imlet.2007.08.005. Epub 2007 Sep 14. Review. PubMed PMID: 17936914; PubMed Central PMCID: PMC2094047.
Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2007 Jan 1;178(1):280-90. doi: 10.4049/jimmunol.178.1.280. PubMed PMID: 17182565.
Taylor DK, Walsh PT, LaRosa DF, Zhang J, Burchill MA, Farrar MA, Turka LA. Constitutive activation of STAT5 supersedes the requirement for cytokine and TCR engagement of CD4+ T cells in steady-state homeostasis. J Immunol. 2006 Aug 15;177(4):2216-23. doi: 10.4049/jimmunol.177.4.2216. PubMed PMID: 16887981.
Will WM, Aaker JD, Burchill MA, Harmon IR, O'Neil JJ, Goetz CA, Hippen KL, Farrar MA. Attenuation of IL-7 receptor signaling is not required for allelic exclusion. J Immunol. 2006 Mar 15;176(6):3350-5. doi: 10.4049/jimmunol.176.6.3350. PubMed PMID: 16517702.
Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Johanns TM, Farrar MA. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment. J Immunol. 2005 Jun 15;174(12):7753-63. doi: 10.4049/jimmunol.174.12.7753. PubMed PMID: 15944278.
Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM, Schell RF. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immunol. 2004 Nov;11(6):1075-84. doi: 10.1128/CDLI.11.6.1075-1084.2004. PubMed PMID: 15539509; PubMed Central PMCID: PMC524754.
Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, Thompson CB, Burchill MA, Farrar MA, Turka LA. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol. 2004 May 1;172(9):5287-96. doi: 10.4049/jimmunol.172.9.5287. PubMed PMID: 15100267; PubMed Central PMCID: PMC2842445.
Goetz CA, Harmon IR, O'Neil JJ, Burchill MA, Farrar MA. STAT5 activation underlies IL7 receptor-dependent B cell development. J Immunol. 2004 Apr 15;172(8):4770-8. doi: 10.4049/jimmunol.172.8.4770. PubMed PMID: 15067053.
Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, Turka LA, Brennan P, Jameson SC, Farrar MA. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol. 2003 Dec 1;171(11):5853-64. doi: 10.4049/jimmunol.171.11.5853. PubMed PMID: 14634095; NIHMSID:NIHMS34056.
Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun. 2003 Jun;71(6):3437-42. doi: 10.1128/iai.71.6.3437-3442.2003. PubMed PMID: 12761128; PubMed Central PMCID: PMC155727.
What would you like to do?
  • Page of 1